Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |